The Dubousset Functional Test in Total Knee Arthloplasty
DFT-TKA
Validity and Reliability of Dubousset Functional Test in Total Knee Arthloplasty
1 other identifier
observational
60
0 countries
N/A
Brief Summary
The aim of this study is to investigate the validity and reliability of Dubousset Functional Test in the patients with Total Knee Prothesis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Nov 2024
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 8, 2024
CompletedFirst Posted
Study publicly available on registry
October 9, 2024
CompletedStudy Start
First participant enrolled
November 15, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 15, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
July 15, 2025
CompletedOctober 9, 2024
October 1, 2024
7 months
October 8, 2024
October 8, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Dubousset Functional Test
The four test components included the Up and Walking Test (unassisted sit-to-stand from a chair, walk forward/backward 5 meters \[no turn\], then unassisted stand-to-sit), Steps Test (ascend three steps, turn, descend three steps), Down and Sitting Test (stand-to-ground, followed by ground-to-stand, with assistance as needed), and Dual-Tasking Test (walk 5 meters forwards and back while counting down from 50 by 2).
10 minutes
Eligibility Criteria
Patients aged 50-70 years who had Total Knee Arthroplasty
You may qualify if:
- Patients who had Total Knee Arthroplasty
- Patients aged 50-70 years.
You may not qualify if:
- Patients who didn't have any Total Kne arthroplasty
- hose with fractures, pregnancy, a disease that would prevent physical exertion, those with a body mass index (BMI) of 40 kg/m2 and above, and those with major musculoskeletal or neurological disorders that cause gait disturbance will be excluded from the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Asistant Professor, Physiotherapist
Study Record Dates
First Submitted
October 8, 2024
First Posted
October 9, 2024
Study Start
November 15, 2024
Primary Completion
June 15, 2025
Study Completion
July 15, 2025
Last Updated
October 9, 2024
Record last verified: 2024-10
Data Sharing
- IPD Sharing
- Will not share